Ticker Shock!

Ticker Shock!

Viking Therapeutics Stock CRASHES: Weight Loss Pill Trial Sparks Investor Panic! #stockanalysis

7 min · 20 de ago de 2025
Portada del episodio Viking Therapeutics Stock CRASHES: Weight Loss Pill Trial Sparks Investor Panic! #stockanalysis

Descripción

Viking Therapeutics (VKTX) just dropped a bombshell: their Phase 2 trial for the oral weight-loss pill VK2735 showed strong results—but also a massive dropout rate due to side effects like nausea and vomiting. Investors reacted fast, sending the stock down over 40% in a single day.In this episode of Ticker Shock, we break down:The science behind VK2735’s weight-loss resultsWhy the dropout rate is a red flag for future revenueThe math behind Viking’s projected earnings collapseWhat this means for biotech investors and the obesity drug race📉 Is Viking still a “Buy”? Or is this a speculative trap?🔔 Subscribe for more market deep dives and hit the bell so you never miss a shockwave.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Ticker Shock!!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

4 episodios

Portada del episodio Viking Therapeutics Stock CRASHES: Weight Loss Pill Trial Sparks Investor Panic! #stockanalysis

Viking Therapeutics Stock CRASHES: Weight Loss Pill Trial Sparks Investor Panic! #stockanalysis

Viking Therapeutics (VKTX) just dropped a bombshell: their Phase 2 trial for the oral weight-loss pill VK2735 showed strong results—but also a massive dropout rate due to side effects like nausea and vomiting. Investors reacted fast, sending the stock down over 40% in a single day.In this episode of Ticker Shock, we break down:The science behind VK2735’s weight-loss resultsWhy the dropout rate is a red flag for future revenueThe math behind Viking’s projected earnings collapseWhat this means for biotech investors and the obesity drug race📉 Is Viking still a “Buy”? Or is this a speculative trap?🔔 Subscribe for more market deep dives and hit the bell so you never miss a shockwave.

20 de ago de 20257 min
Portada del episodio First Solar STOCK SURGE! 🚀 Tax Credit Shake‑Up Could Supercharge FSLR Earnings

First Solar STOCK SURGE! 🚀 Tax Credit Shake‑Up Could Supercharge FSLR Earnings

The U.S. Treasury just dropped a game‑changing update to clean energy tax credit rules — and First Solar (FSLR) may be the biggest winner. In this Ticker Shock breakdown, we unpack what the new guidance means, how it impacts solar developers, and why FSLR stock jumped over 10% in a single day. We’ll cover: * The 5% safe harbor change — and why big projects must now show real progress * How this news affects First Solar’s revenue, EPS, and U.S. market dominance * Analyst reactions and what it could mean for your investment strategy 📈 Don’t miss: Price action charts, potential EPS boost scenarios, and our HOLD verdict until Q3/Q4 results confirm the hype. 💡 This video is for educational purposes only — not financial advice. Always do your own research before investing

19 de ago de 20255 min